Cargando…
LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis
Pancreatic cancer (PC) is one of the most lethal human malignancies without effective treatment. In an effort to discover key genes and molecular pathways underlying PC growth, we have identified LIM domain only 7 (LMO7) as an under-investigated molecule, which highly expresses in primary and metast...
Autores principales: | Liu, Xinjian, Yuan, Hao, Zhou, Jing, Wang, Qiongling, Qi, Xiaoqiang, Bernal, Catharine, Avella, Diego, Kaifi, Jussuf T., Kimchi, Eric T., Timothy, Parrett, Cheng, Kun, Miao, Yi, Jiang, Kuirong, Li, Guangfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982467/ https://www.ncbi.nlm.nih.gov/pubmed/33763427 http://dx.doi.org/10.3389/fcell.2021.647387 |
Ejemplares similares
-
Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy
por: Zhou, Jing, et al.
Publicado: (2021) -
Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response
por: Qi, Xiaoqiang, et al.
Publicado: (2020) -
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice
por: Li, Guangfu, et al.
Publicado: (2018) -
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018) -
PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2019)